Leukemia begins with DNA changes in bone marrow, causing abnormal blood cells. Blood tests find unusual or immature cells. Treatment varies by type, overall health, and disease spread.
No Data Available
The term leukemia is made from two words: “white” (leukos) and “blood” (haima).
Leukemia is a form of cancer that affects the blood-forming tissues of the body, including the bone marrow as well as the lymphatic system.
By definition, leukemia is the rapid proliferation of dysfunctional white blood cells that accumulate in the blood and bone marrow, impeding the production of proper blood cells. Thus an individual with leukemia will lack normal red blood cells, platelets, and functional white blood cells. This can cause fatigue, infections, easy bruising or bleeding, and many other complications.
Leukemia does not form a mass (tumor) that can be seen in imaging tests like X-rays, or CT scans. Many types of leukemia occur. Some affect children, while others are more common in adults. Therefore, a blood test for leukemia in adults and children may be suggested depending on if it is acute or chronic, and most importantly, according to which blood cells are implicated.
In certain instances, leukemia can develop suddenly, especially in the case of acute leukemia. The symptoms of acute leukemia are visible in days/weeks and can mimic the flu with fever, malaise, and easy bruising/bleeding, so possibly requiring emergency evaluation.
Chronic leukemia, on the other hand, develops over months/years and can show little or no symptoms initially. It is diagnosed as an incidental finding during a blood test during a physical exam.
Leukemia originates when DNA mutates in a stem cell in the bone marrow and subsequently alters the blood cell formation process. Blood cells pass through many stages before reaching the maturation stage. Mature, normal blood cells include:
When blood cells develop normally, they mature into specified forms. They are categorized as:
A doctor suggests a blood test for leukemia to detect abnormal blood cell counts and to identify immature or abnormal cells.
Since leukemia disrupts the normal function and production of blood cells, a blood test can help reveal high white blood cell counts, low red blood cells or platelet counts, and leukemia cells. It is crucial to diagnose the disease and guide further evaluation and treatment.
It disrupts the normal blood cell production in the bone marrow. Abnormal white blood cells grow out of control and invade normal red blood cells, white blood cells, and platelets. This leads to several problems:
The classification of leukemia depends on how fast the disease spreads and its severity and whether leukemia cells arise from myeloid cells or lymphoid cells.
1. Acute lymphocytic leukemia (ALL) is also known as lymphoblastic leukemia. This cancer type begins in the bone marrow. It affects lymphoid cells, specifically immature lymphocytes ( a type of white blood cell) that overproduce rapidly and can crowd out normal blood cells in the bone marrow.
2. Acute Myeloid Leukemia (AML): This cancer type starts in the bone marrow and leads to rapid and uncontrolled growth of abnormal myeloid cells. These cells are precursors to several types of blood cells, including granulocytes & monocytes (both types of white blood cells) and platelets.
3. Chronic Lymphocytic Leukemia (CLL) affects the blood and bone marrow, specifically involving abnormal growth of white blood cells, called lymphocytes, mainly B cells. In CLL, the bone marrow produces too many lymphocytes in the blood, bone marrow, lymph nodes, and sometimes liver and spleen. The abnormal lymphocytes resemble normal lymphocytes but do not function properly, especially in fighting infections.
Further, the abnormal cells multiply slowly over time, crowding out the healthy blood cells and potentially leading to complications from anemia, infections, or easy bleeding.
4. Chronic Myeloid Leukemia (CML) also known as chronic myelogenous leukemia, is a type of blood cancer that occurs in the bone marrow and primarily affects myeloid cells, especially granulocytes (A type of white blood cells).
Leukemia is a smaller percentage of cancers in India but it is not among the most common cancers overall. Cancer incidence in India is rising, with an estimated 1.46 million new cancer cases in 2022, and approx. 1.57 million in 2025.
Leukemia can affect people of all ages, but it is more common among people who:
Leukemia is the most common type of cancer in children and is the leading form of cancer among both sexes. For all ages, leukemia is among the most frequent malignancies when analyzed by type, but cancers like lung and breast cancer are more prevalent overall in adults.
You may or may not develop noticeable symptoms in the early stages depending on, in part, on the type of leukemia. Some common symptoms include:
Leukemia begins when the single cell DNA in your bone marrow changes. DNA is the “instruction code” that tells a cell when to grow, how to grow, and when to die due to mutation, or coding error, leukemia cells keeps multiplying,
Researchers believe several factors are known to increase the risk of developing leukemia. These risk factors can be genetic, lifestyle, and environmental factors. Most importantly, people with known risks do not develop leukemia, and many individuals with leukemia have no identifiable risk factors.
|
Category |
Examples |
|
Genetic/inherited Factors |
Down syndrome, Fanconi anaemia, family history |
|
Environmental/Chemical Factors |
Radiation, Benzene, Formaldehyde, Agent Orange, Pesticides. |
|
Previous Cancer Therapy |
Chemotherapy/radiation therapy |
|
Lifestyle |
Smoking, drinking, obesity |
|
Infections/other |
HTLV-1, EBV, chronic food disorders |
Yes, certain people are at a higher risk of developing leukemia. Those with increased risk include individuals exposed to high levels of radiation or certain chemicals (like benzene), smokers, people with a history of radiation therapy or chemotherapy, and those with rare genetic syndromes such as Down syndrome, neurofibromatosis, Klinefelter syndrome, Schwachman-Diamond syndrome, Fanconi anemia, or Bloom syndrome.
Advancing age, being male, and having a family history of leukemia can also raise the risk. However, most people with these risk factors do not develop leukemia, and many who do have no known risk factors.
Leukemia is diagnosed through a series of steps and tests, typically beginning with a medical examination and followed by specialized laboratory procedures.
A blood test for leukemia results may indicate:
A high white blood cell count, leukocytosis, is a common finding in leukemia. It occurs when the count exceeds 11,000 microliter. Elevated counts can also occur due to infections or other conditions.
On the other hand, some people with leukemia may experience a low white blood cell count, or leukopenia that can crowd out normal blood cells in the bone marrow. Both these findings are crucial indicators of leukemia and are usually evaluated with other white blood cell counts and clinical findings.
Leukeia is treated depending on the type of leukemia you have, your age, and overall health. Common treatments for leukemia include the following:
There are three phases of leukemia treatment: Induction therapy, Consolidation or Intensification, and Maintenance therapy.
Induction therapy helps kill as many leukemia cells and obtain remission. Remission means that the blood and bone marrow are free of leukemia cells and the body is producing normal blood cells.
Induction therapy lasts about a month and is started as soon as possible from the time of diagnosis. It is successful if it achieves remission (leukemia cells are less than 5% in the bone marrow) and normal blood cell counts.
Once you have received remission, consolidation or intensification aims to destroy any remaining leukemia cells that may not be detectable through standard tests but could relapse. Using consolidating remission it may be possible to limit or avoid having leukemia relapse.
Additionally, consolidation therapy usually lasts a few months; however, the exact length of time depends on the protocol and individual risk factors. Healthcare professionals may order a stem cell transplantation as a part of consolidation for higher-risk patients.
Maintenance therapy keeps leukemia in remission by killing any remaining leukemia cells that might regrow and cause relapse. This therapy is useful for ALL.
Additionally, maintenance therapy usually lasts approximately two years for ALL, including the time spent in this phase. Regular blood tests and clinic visits are suggested for close monitoring.
Note: Healthcare providers may modify your treatment for leukemia if needed.
If you are diagnosed with leukemia, your outcomes depend on several factors, including the specific type of leukemia, your age, overall health, and how well the cancer responds to treatment.
| Types of Cancer | Survival Rates |
| 1. Chronic lymphocytic leukemia (CLL) | 5-year (about 88-88.5%) |
| 2. Chronic myeloid leukemia (CML) | 5 years (about 70%) |
| 3. Acute lymphocytic leukemia (ALL) | Approx. 71-72% overall, but can exceed 90% in children under 20. |
| 4. Acute myeloid leukemia (AML) | Approx. 5 years (About 31–32% overall, but higher in younger patients (up to 69% in those under 20) |
| 5. Chronic Myelomonocytic leukemia (CMML) | Poorer prognosis (10-20%) |
7.The presence of leukemia cells in your central nervous system is serious and linked to a significantly worse prognosis. The involvement of CNS makes the treatment more complicated, often leading to lower survival rates.
Hence, there is no need to delay getting a blood test for leukemia detection done. Early diagnosis of leukemia improves prognosis, so prompt testing is crucial if you are facing unexplained fatigue, weight loss, frequent infections, or easy bruising.
The survival of leukemia depends on the specific type and age group, but overall, recent statistics show:
| Types of Leukemia | 5 Year Survival Rate | Number of deaths per 100, 000 persons | Age bracket with the highest death rate |
| Acute Lymphocytic Leukemia (ALL) | 67-70% | Males: 0.5 per 100, 000 Females: 0.3 per 100, 000 |
65-84 |
| Acute Myeloid Leukemia (AML) | 31.7% | Males: 3.4 per 100, 000 Females: 2.1 per 100, 000 |
65+ |
| Chronic Lymphocytic Leukemia (CLL) | 88.0% | Males: 1.6 per 100, 000 Females: 0.7 per 100, 000 |
75+ |
| Chronic Myelogenous Leukemia (CML) | 70.6% | Males: 0.4 per 100, 000 Females: 0.2 per 100, 000 |
75+ |
When a disease is cured, it means it won’t come back and no further treatment is needed. Early diagnosis can help a healthcare provider suggest the most appropriate treatment, almost eliminating the chances of relapse.
Certain types of leukemia such as acute lymphoblastic leukemia (ALL) is considered curable in children with long-term survival rates exceeding 90% in many cases. Chronic myeloid leukemia (CML) is also considered highly treatable, and with modern targeted therapies, you can achieve long-term remission and nearly normal life expectancy.
Not every leukemia can be cured. Treatment outcomes depend upon the specific type of leukemia, your age, overall health, and effectiveness of treatment. Often younger patients with favorable conditions can be cured, others may experience long-term remission or require ongoing management.
Do not feel shy to ask your doubts to your healthcare provider. The more you ask, the more you will have clarity about your health condition with leukemia and get appropriate suggestions.
Questions you may ask:
If a blood test suggests leukemia additional specific testing such as bone marrow biopsy or flow cytometry is required to confirm the diagnosis of leukemia and its type. Consult your doctor to understand the blood test for leukemia results crucial for a personalized care plan.
Redcliffe Labs is committed to providing accurate, reliable, and timely diagnostic services to support your health and wellness journey. Our comprehensive range of tests, including full body checkups, specialized blood tests, and cancer screenings is designed to help detect health issues early and empower you with actionable insights.
With our user-friendly mobile app and doorstep sample collection, you can book a blood test for leukemia in adults and children at your convenience and access your reports online.